UIP1 inhibitors are a class of chemical compounds that specifically target and inhibit the activity of the UIP1 (Ubiquitin Interaction Protein 1) enzyme. UIP1 is involved in processes related to protein degradation via the ubiquitin-proteasome system, which plays a crucial role in maintaining cellular protein homeostasis. This enzyme interacts with ubiquitinated proteins, facilitating their recognition and subsequent degradation. By inhibiting UIP1, these compounds can disrupt the degradation process, resulting in the accumulation of ubiquitinated proteins. The study of UIP1 inhibitors allows researchers to explore the mechanisms behind protein turnover and understand how cells regulate protein quality control under various conditions.
In research settings, UIP1 inhibitors are valuable tools for investigating the ubiquitin-proteasome pathway and its role in different cellular processes such as protein folding, stress responses, and cell cycle progression. These inhibitors provide insights into how cells manage protein levels and maintain homeostasis by removing damaged or misfolded proteins. Additionally, UIP1 inhibitors help elucidate the role of ubiquitin interaction proteins in signaling pathways, allowing scientists to study how ubiquitin modifications influence protein stability and function. By modulating UIP1 activity, researchers can also investigate the broader implications of ubiquitin-related mechanisms, including the regulation of protein interactions, cellular localization, and post-translational modifications. The use of UIP1 inhibitors thus contributes to a deeper understanding of cellular proteostasis and protein regulatory networks.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin enhances adenylate cyclase activity, increasing cAMP levels, which could indirectly affect various signaling pathways, potentially impacting UIP1. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a ROCK inhibitor, which can influence cytoskeletal dynamics, possibly affecting UIP1 if it's involved in related processes. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, an HDAC inhibitor, alters chromatin structure and gene expression, potentially impacting UIP1 expression or function. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine, a DNA methyltransferase inhibitor, modifies gene expression patterns, which could indirectly influence UIP1. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor, affecting cellular growth and metabolism, potentially influencing pathways involving UIP1. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB431542 inhibits the TGF-beta receptor, impacting cellular differentiation and proliferation, possibly affecting UIP1. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, influencing cell survival and metabolism, potentially affecting UIP1 activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 inhibits MEK, affecting the MAPK/ERK pathway, which could indirectly influence UIP1. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132, a proteasome inhibitor, affects protein degradation pathways, potentially influencing UIP1. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Bafilomycin A1 inhibits V-ATPase, impacting lysosomal acidification and autophagy, potentially affecting UIP1. | ||||||